Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The webpage has been updated to include the term 'Metastatic Non Small Cell Lung Cancer' and the version has been revised to v2.15.0. Additionally, the name of the principal investigator has been removed, while the collaborators remain the same.
    Difference
    50%
    Check dated 2025-04-16T14:35:56.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.3%
    Check dated 2025-04-09T09:30:01.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:32:40.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T21:14:39.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing some past dates and adding new future dates. This indicates a shift in the timeline of events or availability.
    Difference
    0.4%
    Check dated 2025-02-17T16:41:36.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T10:17:33.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.